Compare AROC & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AROC | APGE |
|---|---|---|
| Founded | 1990 | 2022 |
| Country | United States | United States |
| Employees | N/A | 261 |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.0B |
| IPO Year | 2007 | 2023 |
| Metric | AROC | APGE |
|---|---|---|
| Price | $35.53 | $71.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $37.67 | ★ $103.22 |
| AVG Volume (30 Days) | ★ 1.5M | 696.1K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ 74.29 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $1,489,818,000.00 | N/A |
| Revenue This Year | $7.33 | N/A |
| Revenue Next Year | $5.44 | N/A |
| P/E Ratio | $18.91 | ★ N/A |
| Revenue Growth | ★ 28.70 | N/A |
| 52 Week Low | $20.12 | $26.20 |
| 52 Week High | $37.26 | $84.56 |
| Indicator | AROC | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 60.35 | 49.64 |
| Support Level | $23.23 | $35.24 |
| Resistance Level | $37.26 | $82.77 |
| Average True Range (ATR) | 1.15 | 3.90 |
| MACD | -0.32 | 0.25 |
| Stochastic Oscillator | 42.94 | 45.29 |
Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.